U.S. Biotech Stock News

Silgan Holdings recently announced a series of executive leadership changes, appointing Shawn C. Fabry as Executive Vice President and Chief Financial Officer, alongside key promotions for other senior roles, and confirmed a new US$500 million share repurchase program set to run through 2029. These moves, which include both long-term succession planning and a sizable new capital return initiative, reflect a dual focus on management continuity and shareholder value. We'll now consider how the...

In the past week, Q2 Holdings reported a return to profitability in the third quarter with US$201.7 million in sales, raised its full-year 2025 revenue guidance to US$789 million–US$793 million, and announced a US$150 million share repurchase program. These developments were accompanied by executive leadership changes and reflect management's increased confidence in the company's outlook and operational momentum. We'll examine how Q2 Holdings' strong quarterly earnings and raised guidance...

Check Point Software Technologies (CHKP) shares drew attention after Guardz announced a strategic partnership to integrate Check Point’s Harmony Email into its unified cybersecurity platform. The move aims to boost email security for managed service providers who are facing evolving email-borne threats. See our latest analysis for Check Point Software Technologies. Check Point’s recent jump in investor interest comes alongside news of its partnership with Guardz, a move that could expand its...

Strategy Inc. recently completed a €620 million preferred stock offering in Europe, issuing 7.75 million shares of 10% Series A Perpetual Stream Preferred Stock to support further bitcoin acquisitions and working capital needs. This marks a notable expansion of the company’s bitcoin-financing model into European markets and highlights growing reliance on preferred equity as raising capital through common stock becomes more challenging. We’ll explore how this large-scale fundraising effort,...

CSX (CSX) has announced a series of executive leadership changes, with Kevin Boone stepping in as both executive vice president and chief financial officer. These appointments are intended to support the company’s evolving strategy and long-term growth. See our latest analysis for CSX. CSX’s latest leadership changes come on the heels of an 8.8% year-to-date share price return, but the stock has struggled to keep momentum, with total shareholder return down 1.7% over the past year. While...

Macy's (M) shares edged slightly lower on Monday, giving back some gains from the past month after the stock outperformed the broader retail sector. Investors appear to be watching for signals of changing consumer demand as summer progresses. See our latest analysis for Macy's. Despite some recent volatility, Macy's share price return stands out, with a 23.9% rally over the past month and a 54.8% climb in the last quarter. Momentum has clearly picked up, building on underlying optimism after...

Aflac (AFL) shares are drawing attention as investors watch for new developments that could shape the company’s outlook. Recent trading action has sparked conversation about where the stock might head next. See our latest analysis for Aflac. It has been a steady run for Aflac, with recent momentum building as the share price climbed 4.6% over the past week and notched an 11.2% gain year-to-date. While short-term price movement has been positive, Aflac’s 5-year total shareholder return of 196%...

Brighthouse Financial (BHF) has kept investors’ attention with a steady performance in recent weeks, returning 21% this month. With revenue and net income both growing at a solid pace, the stock continues its upward trend. See our latest analysis for Brighthouse Financial. Brighthouse Financial’s share price has surged 39% over the past month, signaling growing investor confidence and strong momentum after a period of steady gains. Looking back, the company has delivered a 25% total...

Wondering if Apollo Global Management is undervalued, overhyped, or hiding an opportunity? You are not alone; many investors are looking for clues about where the stock is headed next. Recently, the stock has shown a 1.8% gain over the last week and rallied 12.4% in the past month. However, it is still down 17.8% for the year, raising questions about shifting market perception and future potential. News about Apollo’s expanding assets under management and partnerships with major...

Abeona Therapeutics (ABEO) just announced that the Centers for Medicare and Medicaid Services has established a permanent J-code for ZEVASKYN, its gene therapy for RDEB. The code takes effect in January 2026, making billing and access for providers more efficient. See our latest analysis for Abeona Therapeutics. Even with this major regulatory milestone for ZEVASKYN, Abeona Therapeutics’ share price return has been under pressure, with a 30-day retreat of 22.2% and a year-to-date slide of...

Bitdeer Technologies Group recently announced third-quarter 2025 results, reporting a significant jump in revenue to US$169.71 million, substantially driven by increased self-mining activity and new product launches. An interesting insight is Bitdeer's intensified focus on AI infrastructure and expansion of its bitcoin mining capacity, despite continued challenges in profitability. We'll explore how Bitdeer's operational scaling and investment in AI cloud initiatives could impact its broader...

iRhythm Technologies recently reported third quarter 2025 results showing US$192.88 million in sales and a net loss of US$5.21 million, a marked improvement from the same period last year, and raised its full-year 2025 revenue guidance to between US$735 million and US$740 million. This combination of accelerated revenue growth and reduced net losses has underscored building confidence in the company’s operational outlook and future business momentum. We’ll explore how the raised revenue...

Blue Owl Capital Inc. recently reported its third-quarter 2025 results, with revenue rising to US$727.99 million from US$600.88 million a year earlier, while net income decreased to US$6.31 million compared to US$29.81 million last year, and the company affirmed a quarterly dividend of US$0.225 per Class A Share. Despite higher year-over-year revenue and a maintained dividend, the decline in net income and earnings per share stands out as an important development for investors monitoring...

SenesTech, Inc. recently announced that its Evolve® Rat birth Control® product became available for purchase online at Lowes.com, marking a key expansion in retail distribution and consumer accessibility across the home improvement giant’s digital platform. This launch highlights Lowe’s ongoing efforts to broaden its pest control offerings, appealing to both homeowners and professionals while capitalizing on growing interest in humane, sustainable solutions. We’ll now explore how the...

Apellis Pharmaceuticals (APLS) posted third quarter earnings showing a big shift from the prior year. The company moved from a net loss to a strong net profit as revenue more than doubled compared to last year. See our latest analysis for Apellis Pharmaceuticals. Despite Apellis’s jump to profitability and surging third quarter revenue, the share price has slipped recently, with a 1-month share price return of -22.33% and a total shareholder return of -33.32% over the past year. The latest...

On October 31, 2025, Lufax Holding Ltd. announced executive leadership changes, appointing Mr. Xiang Ji as Co-Chief Executive Officer and Mr. Tao Wu as Executive Deputy General Manager and Chief Marketing Officer, both bringing substantial cross-industry expertise to the company. The recruitment of leaders with deep experience in retail credit, insurance, and digital services may influence Lufax’s future strategic direction and market positioning. We will explore how the addition of seasoned...

Earlier this month, Realty Income Corporation announced the declaration of its 665th consecutive monthly dividend and filed for a follow-on equity offering of up to 150 million common shares to raise funds for general corporate purposes such as property investments and debt repayment. The company's ability to maintain uninterrupted monthly dividends for over three decades highlights its reputation for income stability and robust financial management within the real estate investment trust...

In its recent third-quarter update, Coca-Cola reported revenue and margin growth, and director Levchin Max disclosed nearly US$1 million in insider share purchases in late October 2025. Analyst sentiment turned more positive as transparency improved and premium products like Fairlife and Topo Chico contributed to resilient performance despite challenges in the broader consumer staples sector. We’ll explore how increased insider buying and renewed analyst optimism could shape Coca-Cola’s...

Arm Holdings (NasdaqGS:ARM) shares moved higher after the company reported second-quarter results that beat forecasts and offered an upbeat outlook for the next quarter. Investors are taking notice as AI-driven growth is propelling the business forward. See our latest analysis for Arm Holdings. Arm Holdings has had a headline-making few months, with a wave of upbeat earnings, expansion plans into AI-focused chips, and new partnerships fueling investor interest. The stock’s year-to-date share...

Avadel Pharmaceuticals plc recently reported earnings for the third quarter and nine months ended September 30, 2025, posting a net income of US$0.02 million and US$4.77 million for these periods respectively, compared to net losses a year ago. This marks a turnaround for the company, with basic and diluted earnings per share from continuing operations improving from a US$0.46 loss to a US$0.05 profit year-over-year. We'll explore how Avadel's swing to profitability this quarter could impact...

Acushnet Holdings (NYSE:GOLF) delivered a strong third quarter, surpassing sales and adjusted EBITDA forecasts due to continued momentum in its Titleist Golf Equipment segment. Management subsequently raised their outlook for 2025. See our latest analysis for Acushnet Holdings. After a solid third quarter and upbeat guidance lifted investor confidence, Acushnet’s share price has gained 11.3% year to date, with a robust 15.3% total shareholder return over the last twelve months. This...

Bio-Techne (TECH) just released its first-quarter earnings, reporting a jump in net income and earnings per share, even as sales dipped slightly year over year. Alongside earnings, several recent company updates stand out. See our latest analysis for Bio-Techne. Despite Bio-Techne's surge in innovation, from AI-driven biomarker advances unveiled at recent conferences to steady progress on share buybacks and dividends, the stock has yet to spark a reversal in momentum. The 1-year total...

First Horizon (FHN) caught some attention after Barclays reaffirmed its positive view, standing out by maintaining its rating and projecting further upside. This signals a shift in analyst sentiment compared to recent cautious takes. See our latest analysis for First Horizon. First Horizon’s share price has moved steadily this year, with the stock up 8.45% year-to-date and a 12.4% total shareholder return for the past year. While the latest analyst confidence is making waves, recent executive...

BigBear.ai Holdings recently announced its third quarter 2025 earnings, reporting quarterly sales of US$33.14 million, down from US$41.51 million a year earlier, but with net income turning positive at US$2.52 million compared to a loss the previous year. This marks a return to quarterly profitability for the company despite ongoing revenue headwinds, while management’s full-year outlook highlights continued pressure on sales and underlying contract uncertainties. We’ll explore how the mix...